Here we describe the case of a HIV-positive patient with acute hepatitis C virus reinfection, who was successfully treated with an interferon-free regimen of ledipasvir/sofosbuvir.
GhosnJPierre-FrancoisSThibaultV. Acute hepatitis C in HIV-infected men who have sex with men. HIV Med2004; 5: 303–306.
2.
van de LaarTJMatthewsGVPrinsM. Acute hepatitis C in HIV-infected men who have sex with men: an emerging sexually transmitted infection. AIDS2010; 24: 1799–1812.
3.
HaganHJordanAENeurerJ. Incidence of sexually transmitted hepatitis C virus infection in HIV-positive men who have sex with men. AIDS2015; 29: 2335–2345.
4.
RauchARickenbachMWeberR. Unsafe sex and increased incidence of hepatitis C virus infection among HIV-infected men who have sex with men: the Swiss HIV cohort study. Clin Infect Dis2005; 41: 395–402.
5.
DantaMBrownDBhaganiS. Recent epidemic of acute hepatitis C virus in HIV-positive men who have sex with men linked to high-risk sexual behaviours. AIDS2007; 21: 983–991.
6.
GiraudonIRufMMaguireH. Increase in diagnosed newly acquired hepatitis C in HIV positive men who have sex with men across London and Brighton, 2002-2006: is this an outbreak?Sex Transm Infect2008; 84: 111–115.
7.
SchmidtAJRockstrohJKVogelM. Trouble with bleeding: risk factors for acute hepatitis C among HIV-positive gay men from Germany: a case-control study. PloS One2011; 6: e17781–e17781.
8.
van der HelmJJPrinsMdel AmoJ. The hepatitis C epidemic among HIV-positive MSM: incidence estimates from 1990 to 2007. AIDS2011; 25: 1083–1091.
9.
LambersFAEPrinsMThomasX. Alarming incidence of hepatitis C virus re-infection after treatment of sexually acquired acute hepatitis C virus infection in HIV-infected MSM. AIDS2011; 25: F21–F27.
10.
MartinTCMartinNKHickmanM. Hepatitis C virus reinfection incidence and treatment outcome among HIV-positive MSM. AIDS2013; 27: 2551–2557.
11.
IngilizPKrznaricIStellbrinkHJ. Multiple hepatitis C virus (HCV) reinfections in HIV-positive men who have sex with men: no influence of HCV genotype switch or interleukin-28B genotype on spontaneous clearance. HIV Med2014; 15: 355–361.
12.
European AIDS Treatment Network (NEAT) Acute Hepatitis C Infection Consensus Panel. Acute hepatitis C in HIV-infected individuals: recommendations from the European AIDS Treatment Network (NEAT) consensus conference. AIDS2011; 25: 399–409.
13.
BoeseckeCRockstrohJK. How will we manage acute HCV in men having sex with men in the era of all oral therapy?J Viral Hepat2015; 22: 2–7.
14.
European Association for Study of Liver. EASL recommendations on treatment of hepatitis C 2015. J Hepatol2015; 63: 199–236.
15.
MatthewsGVHellardMHaberP. Characteristics and treatment outcomes among HIV-infected individuals in the Australian Trial in Acute Hepatitis C. Clin Infect Dis2009; 48: 650–658.
16.
DorwardJGarrettNScottD. Successful treatment of acute hepatitis C virus in HIV positive patients using the European AIDS Treatment Network guidelines for treatment duration. J Clin Virol2011; 52: 367–369.
17.
FiererDSDieterichDTMullenMP. Telaprevir in the treatment of acute hepatitis C virus infection in HIV-infected men. Clin Infect Dis2014; 58: 873–879.
18.
HullegieSJClaassenMAvan den BerkGE. Boceprevir, peginterferon and ribavirin for acute hepatitis C in HIV infected patients. J Hepatol2016; 64: 807–812.
19.
Fierer DS, Barbati Z, Dieterich D, et al. Sofosbuvir in the treatment of acute HCV infection in HIV-infected men. In: The 66th annual meeting of the American Association for the study of liver diseases, San Francisco, CA, 13–17 November 2015, Abstract 1090.
20.
MillardJDHenryJRizviSS. Direct-acting antivirals for acute hepatitis C in HIV-infected MSM. AIDS2016; 30: 2137–2139.
21.
GrahamCSBadenLRYuE. Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis. Clin Infect Dis2001; 33: 562–569.
22.
NaggieSCooperCSaagM. Ledipasvir and sofosbuvir for HCV in patients coinfected with HIV-1. N Engl J Med2015; 373: 705–713.
23.
Basu P, Shah NJ, John N, et al. Sofosbuvir and ledipasvir versus sofosbuvir and simeprevir combination therapy in the management of acute hepatitis C: a randomized open label prospective clinical pilot study. SLAM C study. Interim data. In: The 66th annual meeting of the American association for the study of liver diseases, San Francisco, CA, 13–17 November 2015, Abstract 1074.
24.
Deterding K, Spinner C, Schott E, et al. Six weeks of sofosbuvir/ledipasvir (SOF/LDV) are sufficient to treat acute hepatitis C virus genotype 1 monoinfection: the HEPNET Acute HCV IV study. In: The 51st annual meeting of the European Association for the study of the liver, Barcelona, Spain, 13–17 April 2016, Abstract LBO8.
25.
Rockstroh JK, Bhagani S, Hyland RH, et al. Ledipasvir/sofosbuvir for 6 weeks in HIV-infected patients with acute HCV infection. In: Conference on retroviruses and opportunistic infections 2016, Boston, MA, 22–25 February 2016. Abstract 154LB3.
